Training creative and productive academicians is a critical mission of gastroenterology programs. Emerging discoveries in related fields ranging from human genetics to molecular and cellular biology, microbiology and epidemiology have had major impacts on the understanding of pathophysiology of gastrointestinal diseases. The UCSF Division of Gastroenterology has been a leader in gastrointestinal research for over 40 years. In addition, allied Divisions and Departments at UCSF augment the training program by providing complementary and synergistic training experiences. During the past funding cycle, we have renewed our selection and training procedures to optimize the success of our trainees. The enhanced pool of applicants and trainees in our program attests to the success of our efforts. In this application, we propose to continue our training of innovative and creative academic investigators in gastroenterology.
This application is for support of four training positions in an established program in digestive diseases that has been funded since 1975 at the Division of Gastroenterology, University of California, San Francisco. The Program's goal is preparing trainees for careers in academic luminal gastroenterology, and its track record in this regard is outstanding, with numerous graduates of the program now in leadership positions. The training environment is broadly interdisciplinary, reflecting the synergistic relationships of the Division of Gastroenterology with the IBD Center, the Immunology Program, the Cancer Center, the Institute of Molecular Medicine, and the graduate programs for Biomedical Sciences and Biological Sciences. These broadly interdisciplinary setting provides an ideal training environment for academic gastroenterologists of the future. NOTE: The criteria scores and the critiques given below were provided by the reviewers assigned to this application. These do not necessarily reflect the positions of the reviewers at the close of the group discussion or the final majority opinion of the group, although the reviewers were asked to amend their criteria scores and critiques if their positions changed during the discussion. Please note that the criteria scores are not averaged in arriving at the final overall impact scores. If the reviewers have not changed their criteria scores after the discussion, those shown in the critiques may reflect the opinion of the reviewers before the meeting. The Resume and other initial sections of the summary statement are the authoritative representations of the final outcome of the group discussion. If there is any discrepancy between the reviewers'commentaries and the priority/impact score on the face page of this summary statement, the priority/impact score should be considered the most accurate representation of the final outcome of the group discussion.
|Whang, Michael I; Tavares, Rita M; Benjamin, Daniel I et al. (2017) The Ubiquitin Binding Protein TAX1BP1 Mediates Autophagasome Induction and the Metabolic Transition of Activated T Cells. Immunity 46:405-420|
|Burns, Michael L; Malott, Thomas M; Metcalf, Kevin J et al. (2016) Pro-region engineering for improved yeast display and secretion of brain derived neurotrophic factor. Biotechnol J 11:425-36|
|Onizawa, Michio; Oshima, Shigeru; Schulze-Topphoff, Ulf et al. (2015) Erratum: The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat Immunol 16:785|
|Jensen, Christopher D; Doubeni, Chyke A; Quinn, Virginia P et al. (2015) Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol 13:739-46|
|Ma, Averil (2015) From trash collectors to guardians of cell signaling and immune homeostasis. Immunol Rev 266:1-5|
|Duong, Bao H; Onizawa, Michio; Oses-Prieto, Juan A et al. (2015) A20 restricts ubiquitination of pro-interleukin-1? protein complexes and suppresses NLRP3 inflammasome activity. Immunity 42:55-67|
|Onizawa, Michio; Oshima, Shigeru; Schulze-Topphoff, Ulf et al. (2015) The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nat Immunol 16:618-27|
|Lee, Jeffrey K; Jensen, Christopher D; Lee, Alexander et al. (2015) Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc 81:575-582.e4|
|Corley, Douglas A; Jensen, Christopher D; Marks, Amy R et al. (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370:1298-306|
|Lee, Jeffrey K; Liles, Elizabeth G; Bent, Stephen et al. (2014) Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med 160:171|
Showing the most recent 10 out of 54 publications